Cytokines, modified lipoproteins, and arteriosclerosis in diabetes

Diabetes

Volumn 45, Issue 3 SUPPL., 1996, Pages

  Lopes Virella, Maria F ^a,b,c   Virella, Gabriel ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLESTEROL ESTER; CYTOKINE; INTERLEUKIN 1BETA; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNITY; CONFERENCE PAPER; DIABETES MELLITUS; FIBROBLAST; HUMAN; LIPID STORAGE; MACROPHAGE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION;

ANTIGEN-ANTIBODY COMPLEX; ARTERIOSCLEROSIS; AUTOANTIBODIES; CYTOKINES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; RECEPTORS, LDL;

EID: 0029901505     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.3.s40     Document Type: Article

References (11)

1. Witztum JL, Steinbrecher UP, Kesaniemi YA, Fisher M: Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus. Proc Nail Acad Sci USA 81:3204-3208, 1984
2. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL: Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992
3. Virella G, Virella I, Leman RB, Pryor MB, Lopes-Virella MF: Antioxidized low density lipoprotein antibodies in patients with coronary disease and normal healthy volunteers. Int J Clin Lab Res 23:95-101, 1993
4. Steinbrecher UP, Zhang HF, Lougheed M: Role of oxidatively modified LDL in atherosclerosis. Free Radical Biol Med 9:155-168, 1990
5. Hoff HF, O'Neil J, Chisolm GM, Cole TB, Quehenberger O, Esterbauer H, Jürgens G: Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. Arteriosclerosis 9:538-549, 1989
6. Fogelman AM, Schechter I, Seager J, Hokom M, Child JS, Edwards PA: Malondialdehyde alteration of LDL leads to cholesterol ester accumulation in human monocytes/macrophages. Proc Natl Acad Sci USA 77: 2214-2218, 1980
7. Griffith RL, Virella GT, Stevenson HC, Lopes-Virella MF: LDL metabolism by human macrophages activated with LDL-immune complexes. J Exp Med 168:1041-1009, 1988
8. Gissinger C, Virella GT, Lopes-Virella MF: Erythrocyte-bound LDL immune complexes lead to CE accumulation in human macrophages. Clin Immunol Immunopathol 59:37-51, 1991
9. Jäättelä M: Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin. Lab Invest 64:724-742, 1991
10. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652, 1991
11. Cathcart MK, McNally AK, Morel DW, Chisolm GM: Superoxide anion participation in human monocyte mediated oxidation of LDL and conversion of LDL to a cytotoxin. J Immunol 142:1963-1969, 1989